Ceftibuten

Revision as of 19:45, 30 December 2013 by Gerald Chi (talk | contribs) (Changed protection level for "Ceftibuten" ([Edit=Allow only autoconfirmed users] (expires 19:45, 6 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:45, 6 January 2014 (UTC))))
Jump to navigation Jump to search
Ceftibuten
File:Ceftibuten.png
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H14N4O6S2
Molar mass410.427 g.mol-1

WikiDoc Resources for Ceftibuten

Articles

Most recent articles on Ceftibuten

Most cited articles on Ceftibuten

Review articles on Ceftibuten

Articles on Ceftibuten in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ceftibuten

Images of Ceftibuten

Photos of Ceftibuten

Podcasts & MP3s on Ceftibuten

Videos on Ceftibuten

Evidence Based Medicine

Cochrane Collaboration on Ceftibuten

Bandolier on Ceftibuten

TRIP on Ceftibuten

Clinical Trials

Ongoing Trials on Ceftibuten at Clinical Trials.gov

Trial results on Ceftibuten

Clinical Trials on Ceftibuten at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ceftibuten

NICE Guidance on Ceftibuten

NHS PRODIGY Guidance

FDA on Ceftibuten

CDC on Ceftibuten

Books

Books on Ceftibuten

News

Ceftibuten in the news

Be alerted to news on Ceftibuten

News trends on Ceftibuten

Commentary

Blogs on Ceftibuten

Definitions

Definitions of Ceftibuten

Patient Resources / Community

Patient resources on Ceftibuten

Discussion groups on Ceftibuten

Patient Handouts on Ceftibuten

Directions to Hospitals Treating Ceftibuten

Risk calculators and risk factors for Ceftibuten

Healthcare Provider Resources

Symptoms of Ceftibuten

Causes & Risk Factors for Ceftibuten

Diagnostic studies for Ceftibuten

Treatment of Ceftibuten

Continuing Medical Education (CME)

CME Programs on Ceftibuten

International

Ceftibuten en Espanol

Ceftibuten en Francais

Business

Ceftibuten in the Marketplace

Patents on Ceftibuten

Experimental / Informatics

List of terms related to Ceftibuten


Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent, with 2 dosage forms, capsule or oral suspension. It is marketed by Shionogi USA under the trade name Cedax®

Clinical use

Indications

Cefalexin is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.

Formulations

Ceftibuten is available as capsules containing 400 mg, and a powder for oral suspension containing 90 mg per 5 ml.

See also

External links


Template:WS